Article
An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers
2023-01-01
Abstract excerpt
Non-small cell lung cancer (NSCLC) is the most prevalent and fatal lung cancer. The multiepitope vaccine is one of the immunotherapies successfully applied to treat NSCLC. We designed a multiepitope vaccine with MHC-I, MHC-II, CTL, and linear B cell epitopes of MAGE-A3, EGF, and MUC-1 oncoproteins employing in silico immunoinformatics approach. The structural assessment of the vaccine showed it as a well-stable pr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d92b533a-aa03-5aca-b247-0e05b747a78b
- DOI
- 10.1016/j.imu.2023.101169
